Diphtheria-Tetanus-Acellular Pertussis Vaccine Adsorbed (Triacelluvax; DtaP3-Cb)
Anna J.Matheson, K.L.G.
Pediatric Drugs 2(2): 139-159
2000
ISSN/ISBN: 1174-5878
DOI: 10.2165/00148581-200002020-00007
Accession: 068042511
PDF emailed within 0-6 h: $19.90
Related References
Matheson, A.J.; Goa, K.L. 2000: Diphtheria-tetanus-acellular pertussis vaccine adsorbed (Triacelluvax; DTaP3-CB): a review of its use in the prevention of Bordetella pertussis infection Paediatric Drugs 2(2): 139-159Bernstein, H.H.; Garrison, K.; Marchant, C.D. 1997: Safety and immunogenicity of diphtheria-tetanus-acellular pertussis vaccine adsorbed , Connaught diphtheria-tetanus-acellular pertussis vaccine adsorbed , and diphtheria-tetanus-pertussis vaccine adsorbed in 2,4, and 6 month old infants Pediatric Research 41(4 Part 2): 117A
Bartels, I.; Jüngert, J.; Lugauer, S.; Stehr, K.; Heininger, U. 2001: Immunogenicity and reactogenicity of a single dose of a diphtheria--tetanus--acellular pertussis component vaccine (DTaP) compared to a diphtheria--tetanus toxoid (Td) and a diphtheria toxoid vaccine (d) in adults Vaccine 19(23-24): 3137-3145
Langley, J.M.; Predy, G.; Guasparini, R.; Law, B.; Diaz-Mitoma, F.; Whitstitt, P.; Tapiero, B.; Dionne, M.; Tomovici, A.; Mills, E.; Halperin, S.A. 2007: An adolescent-adult formulation tetanus and diptheria toxoids adsorbed combined with acellular pertussis vaccine has comparable immunogenicity but less reactogenicity in children 4-6 years of age than a pediatric formulation acellular pertussis vaccine and diphtheria and tetanus toxoids adsorbed combined with inactivated poliomyelitis vaccine Vaccine 25(6): 1121-1125
Howe, B.J. 1996: Diphtheria-tetanus-acellular pertussis (DTaP) vaccine JAMA 276(22): 1803-1804
Glanz, J.M.; Narwaney, K.J.; Newcomer, S.R.; Daley, M.F.; Hambidge, S.J.; Rowhani-Rahbar, A.; Lee, G.M.; Nelson, J.C.; Naleway, A.L.; Nordin, J.D.; Lugg, M.M.; Weintraub, E.S. 2013: Association between undervaccination with diphtheria, tetanus toxoids, and acellular pertussis (DTaP) vaccine and risk of pertussis infection in children 3 to 36 months of age JAMA Pediatrics 167(11): 1060-1064
Podda, A.; Bona, G.; Canciani, G.; Pistilli, A.M.; Contu, B.; Furlan, R.; Meloni, T.; Stramare, D.; Titone, L.; Rappuoli, R. 1995: Effect of priming with diphtheria and tetanus toxoids combined with whole-cell pertussis vaccine or with acellular pertussis vaccine on the safety and immunogenicity of a booster dose of an acellular pertussis vaccine containing a genetically inactivated pertussis toxin in fifteen- to twenty-one-month-old children. Italian Multicenter Group for the Study of Recombinant Acellular Pertussis Vaccine Journal of Pediatrics 127(2): 238-243
Daley, M.F.; Yih, W.K.; Glanz, J.M.; Hambidge, S.J.; Narwaney, K.J.; Yin, R.; Li, L.; Nelson, J.C.; Nordin, J.D.; Klein, N.P.; Jacobsen, S.J.; Weintraub, E. 2014: Safety of diphtheria, tetanus, acellular pertussis and inactivated poliovirus (DTaP-IPV) vaccine Vaccine 32(25): 3019-3024
Lee, S.Y.; Hwang, H.S.; Kim, J.H.; Kim, H.H.; Lee, H.S.; Chung, E.H.; Park, S.E.; Ma, S.H.; Chang, J.K.; Guitton, F.; Ortiz, E.; Kang, J.H. 2011: Immunogenicity and safety of a combined diphtheria, tetanus, acellular pertussis, and inactivated poliovirus vaccine (DTaP-IPV) compared to separate administration of standalone DTaP and IPV vaccines: a randomized, controlled study in infants in the Republic of Korea Vaccine 29(8): 1551-1557
Ujiie, M.; Tsuzuki, S.; Suzuki, M.; Ota, M.; Suzuki, T.; Nomoto, H.; Yamamoto, K.; Saito, S.; Kokaze, A.; Kinoshita, N. 2021: Safety of Diphtheria and Tetanus Toxoids and Acellular Pertussis (DTaP) Vaccine in Adults in Japan Japanese Journal of Infectious Diseases 74(5): 399-404
Campbell, N.S.; Kalman, D.D. 2019: Successful vaccination with tetanus and diphtheria and acelluar pertussis vaccine after adverse reaction to diphtheria and tetanus toxoids and acellular pertussis vaccine or diphtheria and tetanus vaccine in pediatric patients Annals of Allergy Asthma and Immunology: Official Publication of the American College of Allergy Asthma and Immunology 123(4): 409-411
Mawas, F.; Dickinson, R.; Douglas-Bardsley, A.; Xing, D.K.L.; Sesardic, D.; Corbel, M.J. 2006: Immune interaction between components of acellular pertussis-diphtheria-tetanus (DTaP) vaccine and Haemophilus influenzae b (Hib) conjugate vaccine in a rat model Vaccine 24(17): 3505-3512
Iwaki, M.; Komiya, T.; Fukuda, T.; Arakawa, Y.; Takahashi, M. 2003: Collaborative study: Standardization of Japanese reference diphtheria and tetanus toxoids, (adsorbed, lot 2), for potency determination of diphtheria-tetanus- acellular pertussis combined vaccine Japanese Journal of Infectious Diseases 56(4): 183-185
Lee, C.Y.; Thipphawong, J.; Huang, L.M.; Lee, P.I.; Chiu, H.H.; Lin, W.; Debois, H.; Harrison, D.; Xie, F.; Barreto, L. 1999: An evaluation of the safety and immunogenicity of a five-component acellular pertussis, diphtheria, and tetanus toxoid vaccine (DTaP) when combined with a Haemophilus influenzae type b-tetanus toxoid conjugate vaccine (PRP-T) in Taiwanese infants Pediatrics 103(1): 25-30
Okada, K.; Miyazaki, C.; Kino, Y.; Ozaki, T.; Hirose, M.; Ueda, K. 2013: Phase Ii and IIi Clinical Studies of Diphtheria-Tetanus-Acellular Pertussis Vaccine Containing Inactivated Polio Vaccine Derived from Sabin Strains (DTaP-sIPV) Journal of Infectious Diseases 208(2): 275-283